Music Intervention for Brain-Heart Disease in Myotonic Dystrophy Type 1 (DM1)
3 other identifiers
interventional
13
1 country
1
Brief Summary
The goal of this interventional study is to demonstrate the feasibility and tolerability of music and movement intervention for children with congenital DM1, while providing indications of its effectiveness in improving brain and heart symptoms of DM1. Additionally, information from the collection of biological samples and wearable devices (accelerometer, EEG headband and ECG chest strap) will be used to identify brain-heart biomarkers and outcome measures for use in future research and trials. Researchers will compare the results of physical and cognitive assessments for each participant to assessments from baseline after 10 weeks of weekly music sessions. Qualitative measures (questionnaires and focus groups) will inform the feasibility of this intervention for this population. The main questions this study aims to answer are:
- Are weekly music education sessions feasible for children with DM1?
- Are weekly music education sessions tolerable for children with DM1? Participants will:
- Attend 45-minute-long music sessions once weekly for 10 weeks.
- Attend two clinic visits for cognitive and physical assessments.
- Provide blood, saliva, stool and urine samples.
- Use wearable devices both at-home and during music sessions.
- Parents/caregivers of participants will complete questionnaires and participate in three focus groups. Progression from feasibility study to a full-scale clinical trial will be informed by four progression criteria:
- The feasibility of attendance, as assessed by attendance rate to 10 music sessions (≥ 60%)
- Feasibility of attendance, as rated by parents/caregivers of participants (≥60% rate "extremely" or "very" practical to attend)
- Attrition rate of the study, as determined by percentage of participants who complete the study (≥ 60%)
- Overall satisfaction, as rated by parents/caregivers of participants (≥60% rate "very satisfied" or "satisfied")
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2025
CompletedFirst Posted
Study publicly available on registry
February 5, 2025
CompletedStudy Start
First participant enrolled
March 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
February 19, 2026
February 1, 2026
1.3 years
January 27, 2025
February 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Attendance to Each Music Session
Participant attendance rate to 10 music sessions.
Over 10-week block of music sessions
Attendance to Block of Music Sessions
The proportion of participants who attend all 10 music sessions.
Over 10-week block of music sessions
Qualitative Feedback from Parents/Caregivers Following Each Music Session
Parents/Caregivers will complete short questionnaires following each of the 10 music sessions. Questions will focus on recall of participant mood, tiredness and engagement in the 24 hours immediately following each music session.
Following each music session through to the final music session.
Secondary Outcomes (22)
Change in Physical Performance Assessed by the 6-Minute Walk Test (6MWT)
Baseline and 1 week following the final music session.
Change from Baseline in Clinical Phenotype Assessed by the Clinician-Completed Congenital DM1 Rating Scale (CDM1-RS)
Baseline and 1 week following the final music session.
Change in Global IQ Assessed by Wechsler Abbreviated Scale of Intelligence Second Edition (WASI-II)
Baseline and 1 week following the final music session.
Change in Attention Assessed by Bells Assessment
Baseline and 1 week following the final music session.
Change in Working Memory Assessed by NIH List Sorting Working Memory Test
Baseline and 1 week following the final music session.
- +17 more secondary outcomes
Study Arms (1)
Music Intervention
EXPERIMENTALAll participants will receive weekly music and movement education sessions.
Interventions
The music and movement intervention is partially inspired by an adaptive music-education method called Dalcroze eurhythmics. It focuses on free and improvised movement, as well as structure and choreographed sequences. It has been successfully applied to similar populations as an effective, accessible, and sustainable intervention. We hope to use this music and movement education to employ a holistic approach to improve the brain-heart symptoms of children with congenital DM1.
Eligibility Criteria
You may qualify if:
- Participants between the ages of 6 to 18 with genetically confirmed congenital or infantile-onset myotonic dystrophy type 1 (DM1).
- Participants willing to stay on stable medication from the day of screening to end of study.
You may not qualify if:
- Insufficient English language skills to complete required assessments and questionnaires.
- Participant is non-verbal.
- Failure to provide signed informed consent by participant or designated decision maker (i.e. parent, legal guardian or power of attorney).
- Failure to provide signed informed consent by parents/caregivers for dyad participation.
- Participant is not a resident of Canada, due to risk of attrition.
- Patients for whom - in the opinion of the investigator - it would not be safe to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hanns Lochmullerlead
- University of Ottawacollaborator
Study Sites (1)
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Senior Scientist
Study Record Dates
First Submitted
January 27, 2025
First Posted
February 5, 2025
Study Start
March 25, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
February 19, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Access Criteria
- IPD will be stored within the ARCHIMEDES health data portal and accessible to qualified researchers with a research plan approved by a data access committee. Supporting information (protocol and informed consent forms) will be available as a publication.
De-identified quantitative data including, results of cognitive and physical assessments and wearable device measurements.